Sort
64,565 grants matching “drug discovery”
Blood vessel assembly from multipotent hemangioma-derived stem cells
$754,352Joyce E. Bischoff · Boston Children'S Hospital · R01 · FY2024 · HL
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
$754,333Yanling Wang · Rush University Medical Center · R01 · FY2023 · AG
Refinement of lead compounds to modulate water permeability through AQP4
$754,297Marc F Pelletier · Aeromics, Inc · R44 · FY2010 · NS
Project 1: Structure, function, and inhibition of SEDS-family peptidoglycan polymerases
$754,286Andrew Kruse · Harvard Medical School · U19 · FY2022 · AI
Discovery of Selective Inhibitors for the EphA4 Kinase
$754,237Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AG
Potent Antifolates as New Therapeutics for MRSA
$754,203Dennis L Wright · Promiliad Biopharma, Inc. · R42 · FY2010 · AI
High-Throughput Screens to Discover Novel Inhibitors of Leaky RyR2 for Heart Failure Therapy
$754,179Razvan Liviu Cornea · University Of Minnesota · R01 · FY2021 · HL
PHARMACOGENOMICS OF ACAMPROSATE TREATMENT OUTCOME
$754,148Victor M. Karpyak · Mayo Clinic Rochester · U01 · FY2019 · AA
High Throughput Screening of Pharmaceuticals Targeting Heart Cell Contractile Function
$754,124Bradley M Palmer · Ionoptix, Llc · R44 · FY2019 · HL
Novel Antimalarials from Fungi
$754,049Debopam Chakrabarti · University Of Central Florida · R01 · FY2024 · AI
Risk Factors for Ischemic Stroke in Women
$753,968Kathryn M Rexrode · Brigham And Women'S Hospital · R01 · FY2022 · HL
Roles of HIV-1 capsid-binding FG-motif containing cellular cofactors in infection
$753,963Mamuka Kvaratskhelia · University Of Colorado Denver · R01 · FY2025 · AI
Development of novel anti-Neisseria gonorrhoeae therapeutic agents
$753,923Daniel Patrick Flaherty · Purdue University · R01 · FY2025 · AI
AN AIDS-RELATED CRYPTOCOCCUS NEOFORMANS GENOME CENTER
$753,798Stanford University · U01 · FY2001 · AI
Glutamatergic adaptation to stress as a mechanism for anhedonia and treatment response with ketamine
$753,755Michael Tilghman Treadway · Emory University · R01 · FY2025 · MH
A Compact X-ray Station for Protein Crystallography
$753,614Jeffrey Rifkin · Lyncean Technologies, Inc. · R44 · FY2008 · GM
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers
$753,506Henning Willers · Massachusetts General Hospital · U01 · FY2021 · CA
Mass Spectrometric Bead-Imaging of Off-Target Drug Interactions
$753,500Mark Lim · Ambergen, Inc · R44 · FY2016 · GM
Mass Spectrometric Bead-Imaging of Off-Target Drug Interactions
$753,500Mark Lim · Ambergen, Inc · R44 · FY2017 · GM
Mass Spectrometric Bead-Imaging of Off-Target Drug Interactions
$753,500Mark Lim · Ambergen, Inc · R44 · FY2018 · GM
The Lymphoid Tissue Pharmacology of Antiretroviral Drugs
$753,498Courtney V. Fletcher · University Of Nebraska Medical Center · R01 · FY2017 · AI
An Imaging Repository for the Cerebrovascular Disease Knowledge Portal (iCDKP)
$753,459Jonathan Rosand · Broad Institute, Inc. · U24 · FY2023 · NS
Target and antibiotic discovery in Bacillus anthracis
$753,447Robert J Haselbeck · Trius Therapeutics, Inc. · R44 · FY2006 · AI
Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria
$753,442Zoltan N. Oltvai · University Of Pittsburgh At Pittsburgh · U01 · FY2006 · AI
Preclinical assessment of GCPII inhibitors for cognition and tau pathology
$753,346Amy F.t. Arnsten · Yale University · R01 · FY2022 · AG